Carteolol

CHEMBL839 Phase 4 已批准 Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

292.4 g/mol

LogP

1.0

Phase

4

A nonselective beta-adrenergic blocking agent with intrinsic sympathomimetic activity used primarily in the management of glaucoma and hypertension. In ophthalmic formulations, it reduces intraocular pressure by decreasing aqueous humor production. Its intrinsic sympathomimetic activity may result in less bradycardia compared to other beta-blockers.

分子量

292.3700 g/mol

LogP

1.00

TPSA

70.60 Å²

Lipinski 五规则

符合

治疗领域

Glaucoma Hypertension

Pharmacokinetics (PK)

Pharmacodynamics (PD)

二维结构

SVG PNG

Cite this structure

Embed this structure

SMILES

CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2

InChI

InChI=1S/C16H24N2O3/c1-16(2,3)17-9-11(19)10-21-14-6-4-5-13-12(14)7-8-15(20)18-13/h4-6,11,17,19H,7-10H2,1-3H3,(H,18,20)

Molecular Formula

C16H24N2O3

HBD / HBA

3 / 4

可旋转键数

6

重原子数

21

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

常见问题

A nonselective beta-adrenergic blocking agent with intrinsic sympathomimetic activity used primarily in the management of glaucoma and hypertension. In ophthalmic formulations, it reduces intraocular pressure by decreasing aqueous humor production. Its intrinsic sympathomimetic activity may result in less bradycardia compared to other beta-blockers.

Yes, Carteolol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL839. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 2583. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

正在寻找患者友好型信息？

Carteolol 在 PillFYI 上

结构

快速数据

分子式: C16H24N2O3
同义词: 1

外部链接

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

医疗免责声明

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.